BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37445737)

  • 1. Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer.
    Ye Q; Wang J; Ducatman B; Raese RA; Rogers JL; Wan YW; Dong C; Padden L; Pugacheva EN; Qian Y; Guo NL
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of deregulated microRNAs in breast cancer progression using FFPE tissue.
    Chen L; Li Y; Fu Y; Peng J; Mo MH; Stamatakos M; Teal CB; Brem RF; Stojadinovic A; Grinkemeyer M; McCaffrey TA; Man YG; Fu SW
    PLoS One; 2013; 8(1):e54213. PubMed ID: 23372687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
    Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
    Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133 expressionand clinicopathologic significance in benign and malignant breast lesions.
    Liu TT; Li XF; Wang L; Yang JL
    Cancer Biomark; 2020; 28(3):293-299. PubMed ID: 32390595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter CpG island hypermethylation during breast cancer progression.
    Park SY; Kwon HJ; Lee HE; Ryu HS; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
    Virchows Arch; 2011 Jan; 458(1):73-84. PubMed ID: 21120523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
    Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression pattern and methylation of estrogen receptor α in breast intraductal proliferative lesions.
    Mao X; Qiao Z; Fan C; Guo A; Yu X; Jin F
    Oncol Rep; 2016 Oct; 36(4):1868-74. PubMed ID: 27498697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of critical genetic changes in human breast disease.
    Ellsworth RE; Ellsworth DL; Deyarmin B; Hoffman LR; Love B; Hooke JA; Shriver CD
    Ann Surg Oncol; 2005 Dec; 12(12):1054-60. PubMed ID: 16228814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape.
    Kader T; Hill P; Rakha EA; Campbell IG; Gorringe KL
    Breast Cancer Res; 2018 May; 20(1):39. PubMed ID: 29720211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma.
    Kader T; Hill P; Zethoven M; Goode DL; Elder K; Thio N; Doyle M; Semple T; Sufyan W; Byrne DJ; Pang JB; Murugasu A; Miligy IM; Green AR; Rakha EA; Fox SB; Mann GB; Campbell IG; Gorringe KL
    J Pathol; 2019 Jul; 248(3):326-338. PubMed ID: 30843206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
    Rahko E; Kauppila S; Pääkkö P; Blanco G; Apaja-Sarkkinen M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Jukkola A
    Tumour Biol; 2009; 30(5-6):257-64. PubMed ID: 19887890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: an immunohistochemical study.
    Umekita Y; Takasaki T; Yoshida H
    Virchows Arch; 1994; 424(5):491-4. PubMed ID: 7913368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
    Yang M; Xu SP; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active surveillance of women diagnosed with atypical ductal hyperplasia on core needle biopsy may spare many women potentially unnecessary surgery, but at the risk of undertreatment for a minority: 10-year surgical outcomes of 114 consecutive cases from a single center.
    Farshid G; Edwards S; Kollias J; Gill PG
    Mod Pathol; 2018 Mar; 31(3):395-405. PubMed ID: 29099502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase expression in atypical ductal hyperplasia in women.
    Santen RJ; Radisky DC; Degnim A; Frost MH; Vachon CM; Ghosh K; Guestini F; McNamara KM; Sasano H
    Breast Cancer Res Treat; 2017 Jun; 163(3):623-629. PubMed ID: 28337664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Utility of SOX10 Immunohistochemical Staining in Breast Pathology.
    Rammal R; Goel K; Elishaev E; Rinda Soong T; Jones MW; Zhao C; Clark BZ; Carter GJ; Yu J; Fine JL; Villatoro TM; Harinath L; Bhargava R
    Am J Clin Pathol; 2022 Nov; 158(5):616-625. PubMed ID: 36000970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type of Architecture, Presence of Punctate Necrosis, and Extent of Involvement in Atypical Ductal Hyperplasia Can Predict the Diagnosis of Breast Carcinoma on Excision: A Clinicopathologic Study of 143 Cases.
    Zhang C; Wang EY; Liu F; Ruhul Quddus M; James Sung C
    Int J Surg Pathol; 2021 Oct; 29(7):716-721. PubMed ID: 33881947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia.
    Pawloski KR; Christian N; Knezevic A; Wen HY; Van Zee KJ; Morrow M; Tadros AB
    Breast Cancer Res Treat; 2020 Dec; 184(3):873-880. PubMed ID: 32857242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences and Relationships Between Normal and Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Invasive Ductal Carcinoma Tissues in the Breast Based on Raman Spectroscopy.
    Han B; Du Y; Fu T; Fan Z; Xu S; Hu C; Bi L; Gao T; Zhang H; Xu W
    Appl Spectrosc; 2017 Feb; 71(2):300-307. PubMed ID: 28181469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.